Summary
- Current Price
- As of today, RGC price is $9.59, up +0.74% on
- Current Price All-Time High
- RGC price is currently -97.47% below its historical high of $379.50 set on
- Market Cap
- RGC current market cap is $5B, down -46.42% year-over-year
- Revenue
- RGC current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RGC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Regencell Bioscience Holdings Limited |
| Ticker | NASDAQ: RGC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Hong Kong |
| IPO | |
| Indexes | Not included |
| Website | regencellbioscience.com |
| Employees | 10 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $9.59 | |
| Price, 1D Change | +0.74% | |
| Market Cap | $5B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.38 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.02 | |
| EPS, 1Y Change | -229.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 38:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$0.02 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $9.59 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.33 | - | |
| - | -$0.01 | - | |
| - | -$0.02 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -46.57% | |
| Price, 3Y | +2,163.39% | |
| Market Cap, 1Y | -46.42% | |
| Market Cap, 3Y | +2,169.78% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -229.17% | |
| EPS, 3Y | +94.75% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $9.59 | |
| SMA 200 | $18.49 | |
| SMA 50 | $6.22 | |
| EMA 200 | $13.33 | |
| EMA 50 | $7.28 | |
| MACD | $0.74 | |
| Beta | 1.38 | |
| ATR | $0.93 | |
| 14-Day RSI | 78.13 | |
| 10-Day Volatility | 120.01% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.02 | |
| Gross Profit | -$404.50K | |
| - | ||
| Operating Income | -$11.72M | |
| - | ||
| Net Income | -$11.70M | |
| - | ||
| EBITDA | -$11.32M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.02 | |
| 10.77 | ||
| 10.77 | ||
| - | ||
| - | ||
| 2,062.24 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 3,899.95 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $13.35M | |
| $14.19M | ||
| $14.73M | ||
| $14.22M | ||
| $1.38M | ||
| $1.32M | ||
| Total Debt | $295.80K | |
| $236.30K | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $11.70M | ||
| $11.32M | ||
| $404.50K | ||
| $0.00 | ||
| $404.50K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$7.70M | ||
| $2.50M | ||
| $16.95M | ||
| Capex | $0.00 | |
| -$7.70M |
Recent analyst updates
No data
Analyst sentiment
Institutional ownership
Screeners with RGC
FAQ
- What is the ticker symbol for Regencell Bioscience Holdings Limited?
- The ticker symbol for Regencell Bioscience Holdings Limited is NASDAQ:RGC
- Does Regencell Bioscience Holdings Limited pay dividends?
- No, Regencell Bioscience Holdings Limited does not pay dividends
- What sector is Regencell Bioscience Holdings Limited in?
- Regencell Bioscience Holdings Limited is in the Healthcare sector
- What industry is Regencell Bioscience Holdings Limited in?
- Regencell Bioscience Holdings Limited is in the Specialty & Generic Drug Manufacturers industry
- What country is Regencell Bioscience Holdings Limited based in?
- Regencell Bioscience Holdings Limited is headquartered in Hong Kong
- When did Regencell Bioscience Holdings Limited go public?
- Regencell Bioscience Holdings Limited initial public offering (IPO) was on July 16, 2021
- Is Regencell Bioscience Holdings Limited in the S&P 500?
- No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index
- Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
- No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index
- Is Regencell Bioscience Holdings Limited in the Dow Jones?
- No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index
- When was Regencell Bioscience Holdings Limited last earnings report?
- Regencell Bioscience Holdings Limited's most recent earnings report was on June 15, 2026
- When does Regencell Bioscience Holdings Limited report earnings?
- The next expected earnings date for Regencell Bioscience Holdings Limited is October 28, 2026
Data Sources & References
- RGC Official Website www.regencellbioscience.com
- RGC Profile on Yahoo Finance finance.yahoo.com/quote/RGC
- RGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgc